[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100551306":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":13,"locations":23,"responsibleParty":43,"collaborators":7,"id":45,"slug":46,"hasResults":47,"nctId":48,"briefTitle":49,"officialTitle":50,"acronym":7,"eligibilityCriteria":51,"healthyVolunteers":47,"sex":52,"minAge":53,"maxAge":7,"enrollmentInfo":54,"targetDuration":7,"studyType":57,"phases":7,"briefSummary":58,"conditions":59,"keywords":7,"overallStatus":26,"whyStopped":7,"lastUpdateSubmitDate":64,"lastUpdatePostDateStruct":65,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":73},{"fullName":5,"class":6},"Helse Møre og Romsdal HF","OTHER_GOV",null,[9],{"name":10,"affiliation":11,"role":12},"Torstein Hole, MD, PhD","Helse Møre og Romsdal HF and NTNU","PRINCIPAL_INVESTIGATOR",[14,19],{"name":15,"role":16,"phone":17,"phoneExt":7,"email":18},"Torstein Hole, Professor, MD, PhD","CONTACT","+4770105000, +4793421002","torstein.hole@helse-mr.no",{"name":20,"role":16,"phone":21,"phoneExt":7,"email":22},"Jørn A Lillebø, consultant cardiology, MD","+4770105000","jorn.asle.lillebo@helse-mr.no",[24],{"facility":25,"status":26,"city":27,"state":28,"zip":29,"country":30,"countryCode":31,"cosmosGeoPoint":32,"geoPoint":37,"contacts":38},"Ålesund Hospital","RECRUITING","Ålesund","Møre og Romsdal","6026","Norway","NO",{"type":33,"coordinates":34},"Point",[35,36],6.15492,62.47225,{"lat":36,"lon":35},[39,41],{"name":40,"role":16,"phone":21,"phoneExt":7,"email":18},"Torstein Hole, PhD",{"name":42,"role":16,"phone":21,"phoneExt":7,"email":22},"Jørn A Lillebø, MD",{"type":44,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100551306","attr-cardiac-amyloidosis-in-a-selected-population-100551306",false,"NCT06458374","ATTR Cardiac Amyloidosis in a Selected Population","Prevalence and Long Tem Follow Up of ATTR Cardiac Amyloidosis in a Selected Population of Patients Operated on Carpal Tunnel Syndrome","Inclusion Criteria:\n\n* Male \\> 50 years\n* Female \\> 60 years\n* operated CTS at Ålesund Hospital\n\nExclusion Criteria:\n\n* not consented\n* do not speak Norwegian\n* secondary cause of CTS as traumatic or rheumatic\n* cannot be followed \\> 5 years due to other medical conditions\n* Cardiac disease at time of operation for CTS","ALL","50 Years",{"count":55,"type":56},180,"ESTIMATED","OBSERVATIONAL","Patients operated for carpal tunnel syndrome (CTS) at Ålesund Hospital (200 patients) will have a biopsy to diagnose ATTR amyloidosis. Patients with positive biopsy will be examined to decide wether they have cardiac amyloidosis. All patients with positive biopsy will be followed closely for 10 years wit echocardiography an clinically.",[60,61,62,63],"ATTR Amyloidosis Wild Type","ATTR Gene Mutation","Carpal Tunnel Syndrome","Cardiac Amyloidosis","2024-10-14",{"date":66,"type":67},"2024-10-16","ACTUAL",{"date":69,"type":67},"2024-09-01",{"date":71,"type":56},"2039-02-28",{"name":5,"class":6},1]